臨床眼科75巻2号

2021年02月発行

連載 今月の話題

線維柱帯細胞による房水流出抵抗の制御

著者： 本庄恵¹

所属機関： ¹東京大学大学院医学系研究科眼科学

ページ範囲：P.143 - P.149

　房水は毛様体で産生され，線維柱帯流出路（主経路）とぶどう膜強膜流出路（副経路）から排出されるが，開放隅角緑内障での眼圧上昇は主に主経路の流出抵抗増加によるとされる。流出抵抗制御のメカニズムにおける線維柱帯細胞の役割について研究が進められており，本稿では房水流出抵抗増加の病態と線維柱帯細胞の関係について考察する。

参考文献

1）Coleman AL：Glaucoma. Lancet 354：1803-1810, 1999

2）Anderson DR：Glaucoma：the damage caused by pressure. XLVI Edward Jackson memorial lecture. Am J Ophthalmol 108：485-495, 1989

3）Civan MM, Macknight AD：The ins and outs of aqueous humour secretion. Exp Eye Res 78：625-631, 2004

4）Carreon T, van der Merwe E, Fellman RL et al：Aqueous outflow-A continuum from trabecular meshwork to episcleral veins. Prog Retin Eye Res 57：108-133, 2017

5）Wiederholt M, Thieme H, Stumpff F：The regulation of trabecular meshwork and ciliary muscle contractility. Prog Retin Eye Res 19：271-295, 2000

6）de Kater AW, Shahsafaei A, Epstein DL：Localization of smooth muscle and nonmuscle actin isoforms in the human aqueous outflow pathway. Invest Ophthalmol Vis Sci 33：424-429, 1992

7）Braunger BM, Fuchshofer R, Tamm ER：The aqueous humor outflow pathways in glaucoma：a unifying concept of disease mechanisms and causative treatment. Eur J Pharm Biopharm 95：173-181, 2015

8）Xin C, Wang RK, Song S et al：Aqueous outflow regulation：optical coherence tomography implicates pressure-dependent tissue motion. Exp Eye Res 158：171-186, 2017

9）O'Callaghan J, Cassidy PS, Humphries P：Open-angle glaucoma：therapeutically targeting the extracellular matrix of the conventional outflow pathway. Expert Opin Ther Targets 21：1037-1050, 2017

10）Gottanka J, Chan D, Eichhorn M et al：Effects of TGF-beta2 in perfused human eyes. Invest Ophthalmol Vis Sci 45：153-158, 2004

11）Mettu P, Deng PF, Misra UK et al：Role of lysophopholipid growth factors in the modulation of aqueous humor outflow facility. Invest Ophthalmol Vis Sci 45：2263-2271, 2004

12）Stamer WD, Read AT, Sumida GM et al：Sphingosine-1-phosphate effects on the inner wall of Schlemm's canal and outflow facility in perfused human eyes 89：980-988, 2009

13）Sumida GM, Stamer WD：Sphingosine-1-phosphate enhancement of cortical actomyosin organization in cultured human Schlemm's canal endothelial cell monolayers. Invest Ophthalmol Vis Sci 51：6633-6638, 2010

14）Stamer WD, Acott TS：Current understanding of conventional outflow dysfunction in glaucoma. Curr Opin Ophthalmol 23：135-143, 2012

15）Inatani M, Tanihara H, Katsuta H et al：Transforming growth factor-beta 2 levels in aqueous humor of glaucomatous eyes. Graefes Arch Clin Exp Ophthalmol 239：109-113, 2001

16）Fuchshofer R1, Tamm ER：The role of TGF-β in the pathogenesis of primary open-angle glaucoma. Cell Tissue Res 347：279-290, 2012

17）Maekawa M, Ishizaki T, Boku S et al：Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science 285：895-898, 1999

18）Rao PV, Pattabiraman PP, Kopczynski C：Role of the Rho GTPase/Rho kinase signaling pathway in pathogenesis and treatment of glaucoma：bench to bedside research. Exp Eye Res 158：23-32, 2017

19）Honjo M, Tanihara H：Impact of the clinical use of ROCK inhibitor on the pathogenesis and treatment of glaucoma. Jpn J Ophthalmol 62：109-126, 2018

20）Picht G, Welge-Luessen U, Grehn F et al：Transforming growth factor beta 2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. Graefes Arch Clin Exp Ophthalmol 239：199-207, 2001

21）Guo T, Guo L, Fan L et al：Aqueous humor levels of TGFβ2 and SFRP1 in different types of glaucoma. BMC Ophthalmol 19：170, 2019

22）Honjo M, Igarashi N, Kurano M et al：Autotaxin-lysophosphatidic acid pathway in intraocular pressure regulation and glaucoma subtypes. Invest Ophthalmol Vis Sci 59：693-701, 2018

23）Honjo M, Igarashi N, Nishida J et al：Role of the Autotaxin-LPA pathway in dexamethasone-induced fibrotic responses and extracellular matrix production in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 59：21-30, 2018

24）Igarashi N, Honjo M, Yamagishi R et al：Involvement of autotaxin in the pathophysiology of elevated intraocular pressure in Posner-Schlossman syndrome. Sci Rep 10：6265, 2020